ES500670A0 - Procedimiento de preparar farmacos con liberacion programada de materia activa. - Google Patents

Procedimiento de preparar farmacos con liberacion programada de materia activa.

Info

Publication number
ES500670A0
ES500670A0 ES500670A ES500670A ES500670A0 ES 500670 A0 ES500670 A0 ES 500670A0 ES 500670 A ES500670 A ES 500670A ES 500670 A ES500670 A ES 500670A ES 500670 A0 ES500670 A0 ES 500670A0
Authority
ES
Spain
Prior art keywords
active principle
procedure
active substance
programmed release
preparing drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES500670A
Other languages
English (en)
Spanish (es)
Other versions
ES8405614A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Publication of ES8405614A1 publication Critical patent/ES8405614A1/es
Publication of ES500670A0 publication Critical patent/ES500670A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES500670A 1980-03-03 1981-03-03 Procedimiento de preparar farmacos con liberacion programada de materia activa. Granted ES500670A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8004728A FR2477015A1 (fr) 1980-03-03 1980-03-03 Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire

Publications (2)

Publication Number Publication Date
ES8405614A1 ES8405614A1 (es) 1984-07-01
ES500670A0 true ES500670A0 (es) 1984-07-01

Family

ID=9239246

Family Applications (1)

Application Number Title Priority Date Filing Date
ES500670A Granted ES500670A0 (es) 1980-03-03 1981-03-03 Procedimiento de preparar farmacos con liberacion programada de materia activa.

Country Status (5)

Country Link
EP (1) EP0036350B1 (OSRAM)
AT (1) ATE5461T1 (OSRAM)
DE (1) DE3161526D1 (OSRAM)
ES (1) ES500670A0 (OSRAM)
FR (1) FR2477015A1 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
DE3710216A1 (de) * 1987-03-27 1988-10-06 Rentschler Arzneimittel Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
AT408198B (de) * 1998-03-25 2001-09-25 Voest Alpine Ind Anlagen Verfahren zum stranggiessen eines dünnen bandes sowie vorrichtung zur durchführung des verfahrens
CN102266310B (zh) * 2011-07-21 2014-01-15 佛山市隆信医药科技有限公司 一种甲磺酸二氢麦角毒碱缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2453640A1 (fr) * 1979-04-12 1980-11-07 Labaz Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotamine

Also Published As

Publication number Publication date
DE3161526D1 (en) 1984-01-05
FR2477015A1 (fr) 1981-09-04
ES8405614A1 (es) 1984-07-01
EP0036350B1 (fr) 1983-11-30
EP0036350A1 (fr) 1981-09-23
ATE5461T1 (de) 1983-12-15
FR2477015B1 (OSRAM) 1983-06-10

Similar Documents

Publication Publication Date Title
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
DE3750145D1 (de) Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
RO91197B (ro) Procedeu pentru prepararea unor derivati de piridazinamina
ATE67933T1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
UA39162C2 (uk) Тверда лікарська форма з регульованим вивільненням активного початку
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
FI881409A0 (fi) Kantajakoostumus kestovaikutteiselle lääkeainevalmisteelle
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
IL98881A0 (en) Esters of heterocyclic compounds,their preparation and pharmaceutical compositions containing them
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
ZA892877B (en) Azelastine-containing medicaments with controlled release of the active substance
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
ES449797A1 (es) Un procedimiento para preparar derivados de 1,3,8-tiazaspiro4,5 deon-4-ona.
MX9203020A (es) Microesferas de diltiazem y composiciones farmaceuticas de liberacion prolongada que las contienen.
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
MY100752A (en) Pharmaceutical composition for combating malaria.
JPS5626910A (en) Preparation of slow-release anticancer complex composition
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.